Jung-Hsin Lin

Title: Jung-Hsin Lin: Innovator in Neurodegenerative Disease Treatment

Introduction

Jung-Hsin Lin is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the prevention and treatment of neurodegenerative diseases and pain. With a total of 3 patents, his work has the potential to impact many lives.

Latest Patents

One of his latest patents focuses on compounds for use in the prevention and treatment of neurodegenerative diseases and pain. This invention discloses compounds selected from various groups, including N-[(3-halothien-2-yl)methyl]adenosine and N-[(4-halothien-2-yl)methyl]adenosine. Another significant patent involves 3,5,N-trihydroxy-alkanamide and its derivatives, which are inhibitors of histone deacetylases (HDACs) and 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase (HMGR). This invention provides methods for using these compounds to treat diseases associated with HDACs or HMGR, including cancer and neurodegenerative diseases.

Career Highlights

Jung-Hsin Lin has worked with esteemed institutions such as Academia Sinica and National Taiwan University. His research has been pivotal in advancing the understanding of compounds that can inhibit drug resistance in cancer cells and treat various diseases.

Collaborations

Some of his notable coworkers include Jim-Min Fang and Ting-Rong Chern. Their collaborative efforts have contributed to the innovative research and development of new pharmaceutical compounds.

Conclusion

Jung-Hsin Lin's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and research have the potential to lead to significant advancements in the treatment of neurodegenerative diseases and other health conditions.